Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration

Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration

The discovery of numerous potent and broad neutralizing antibodies (bNAbs) against Human Immunodeficiency Virus type 1 (HIV-1) envelope glycoprotein has invigorated the potential of using them as an effective preventative and therapeutic agent. The majority of the anti-HIV-1 antibodies, currently un...

Full description

Bibliographic Details
Main Authors: Vaneet K. Sharma, Bijay Misra, Kevin T. McManus, Sreenivas Avula, Kaliappanadar Nellaiappan, Marina Caskey, Jill Horowitz, Michel C. Nussenzweig, Michael S. Seaman, Indu Javeri, Antu K. Dey
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Antibodies
Subjects:
HIV/AIDS
co-formulation
high concentration
analytical characterization
antibody (s)
Online Access:https://www.mdpi.com/2073-4468/9/3/36

Internet

https://www.mdpi.com/2073-4468/9/3/36

Similar Items